Andrew H. Martin is senior vice president and general manager of U.S. Business Operations at Amgen.

Martin joined Amgen in 2025 and brings more than 25 years of global commercial leadership experience in the biopharmaceutical and consumer packaged goods industries.

Most recently, he served as president of U.S. Vaccines at Pfizer, following a tenure of nearly two decades with the company. His previous roles include president of Latin America, responsible for overseeing operations across more than 30 countries, and prior to that he led Rare Disease in Asia Pacific, Africa, the Middle East and Latin America. He has led commercial efforts in rare disease, rheumatology and gastroenterology, shaping U.S. and global strategy.

Martin also held regional and international roles at Johnson & Johnson and Fiskars Brands.

He has an MBA from Cornell University’s Johnson Graduate School of Management and a BA from the University of Pittsburgh.